July 21, 2022 Comments Off on Drug Patent Expirations for the Week of July 17, 2022 Posted in: Uncategorized
LEQVIO (inclisiran sodium) Novartis Patent: 10,590,418 Expiration: Jul 19, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pa…
July 21, 2022 Comments Off on New patent for MIRUM drug LIVMARLI Posted in: Patent Added Annual Drug Patent Expirations for LIVMARLI Livmarli is a drug marketed by Mirum and is included in one NDA. There are two patents protecting this drug. This drug has thirty-two…
The post New patent for MIRUM drug LIVMARLI appeared first on DrugPatentW…
